STING signaling in tumorigenesis and cancer therapy: A friend or foe?

被引：54

作者：

He, Liangmei ^{[1
]}

Xiao, Xiaomei ^{[1
]}

Yang, Xi ^{[2
]}

Zhang, Zixiang ^{[1
]}

Wu, Longhuo ^{[3
]}

Liu, Zhiping ^{[2
]}

机构：

[1] Gannan Med Univ, Affiliated Hosp 1, Ganzhou 341000, Jiangxi, Peoples R China

[2] Gannan Med Univ, Sch Basic Med, Ganzhou 341000, Jiangxi, Peoples R China

[3] Gannan Med Univ, Coll Pharm, Ganzhou 341000, Jiangxi, Peoples R China

来源：

CANCER LETTERS | 2017年 / 402卷

关键词：

STING; Tumorigenesis; Cancer therapy; Metastasis; C-DI-GMP; CYTOSOLIC DNA SENSOR; I INTERFERON; CYCLIC DINUCLEOTIDE; SUPPRESSOR-CELLS; T-CELLS; AUTOIMMUNE-DISEASE; TUMOR-REGRESSION; EPITHELIAL-CELLS; PROSTATE-CANCER;

D O I：

10.1016/j.canlet.2017.05.026

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Stimulator of interferon genes (STING) is a DNA sensor and an important cytoplasmic adaptor for other DNA sensors, such as Z-DNA binding protein 1 (DAI), DEAD-box helicase 41 (DDX41), and interferon-gamma-inducible protein 16 (IF116). The activation of STING signaling leads to the production of type I interferons and some other pro-inflammatory cytokines, which are critical for host defense against viral infection. Recent accumulating evidences suggest that STING is also involved in tumor development. However, the role of STING signaling in tumorigenesis is complicated, and a comprehensive review is still lacking. In this paper, we provided an overview of the dual role of STING signaling in tumor development from clinical significance to fundamental mechanisms, as well as its pre-clinical application in cancer therapy. (C) 2017 Elsevier B.V. All rights reserved.

引用

页码：203 / 212

页数：10

共 116 条

[31] STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors [J].

Deng, Liufu ;

Liang, Hua ;

Xu, Meng ;

Yang, Xuanming ;

Burnette, Byron ;

Arina, Ainhoa ;

Li, Xiao-Dong ;

Mauceri, Helena ;

Beckett, Michael ;

Darga, Thomas ;

Huang, Xiaona ;

Gajewski, Thomas F. ;

Chen, Zhijian J. ;

Fu, Yang-Xin ;

Weichselbaum, Ralph R. .

IMMUNITY, 2014, 41 (05) :843-852

[32] Type I interferon is selectively required by dendritic cells for immune rejection of tumors [J].

Diamond, Mark S. ;

Kinder, Michelle ;

Matsushita, Hirokazu ;

Mashayekhi, Mona ;

Dunn, Gavin P. ;

Archambault, Jessica M. ;

Lee, Hsiaoju ;

Arthur, Cora D. ;

White, J. Michael ;

Kalinke, Ulrich ;

Murphy, Kenneth M. ;

Schreiber, Robert D. .

JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (10) :1989-2003

[33] Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy [J].

Diaz-Montero, C. Marcela ;

Salem, Mohamed Labib ;

Nishimura, Michael I. ;

Garrett-Mayer, Elizabeth ;

Cole, David J. ;

Montero, Alberto J. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (01) :49-59

[34] MULTISTAGE CARCINOGENESIS IN MOUSE SKIN [J].

DIGIOVANNI, J .

PHARMACOLOGY & THERAPEUTICS, 1992, 54 (01) :63-128

[35] The Innate Immune DNA Sensor cGAS Produces a Noncanonical Cyclic Dinucleotide that Activates Human STING [J].

Diner, Elie J. ;

Burdette, Dara L. ;

Wilson, Stephen C. ;

Monroe, Kathryn M. ;

Kellenberger, Colleen A. ;

Hyodo, Mamoru ;

Hayakawa, Yoshihiro ;

Hammond, Ming C. ;

Vance, Russell E. .

CELL REPORTS, 2013, 3 (05) :1355-1361

[36] Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing [J].

Ding, Li ;

Ley, Timothy J. ;

Larson, David E. ;

Miller, Christopher A. ;

Koboldt, Daniel C. ;

Welch, John S. ;

Ritchey, Julie K. ;

Young, Margaret A. ;

Lamprecht, Tamara ;

McLellan, Michael D. ;

McMichael, Joshua F. ;

Wallis, John W. ;

Lu, Charles ;

Shen, Dong ;

Harris, Christopher C. ;

Dooling, David J. ;

Fulton, Robert S. ;

Fulton, Lucinda L. ;

Chen, Ken ;

Schmidt, Heather ;

Kalicki-Veizer, Joelle ;

Magrini, Vincent J. ;

Cook, Lisa ;

McGrath, Sean D. ;

Vickery, Tammi L. ;

Wendl, Michael C. ;

Heath, Sharon ;

Watson, Mark A. ;

Link, Daniel C. ;

Tomasson, Michael H. ;

Shannon, William D. ;

Payton, Jacqueline E. ;

Kulkarni, Shashikant ;

Westervelt, Peter ;

Walter, Matthew J. ;

Graubert, Timothy A. ;

Mardis, Elaine R. ;

Wilson, Richard K. ;

DiPersio, John F. .

NATURE, 2012, 481 (7382) :506-510

[37] Activated STING enhances Tregs infiltration in the HPV-related carcinogenesis of tongue squamous cells via the c-jun/CCL22 signal [J].

Ding, Liang ;

Huang, Xiao-Feng ;

Dong, Guan-Jun ;

Hu, Er-Ling ;

Chen, Sheng ;

Wang, Ting-Ting ;

Hu, Qin-Gang ;

Ni, Yan-Hong ;

Hou, Ya-Yi .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (11) :2494-2503

[38] RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury [J].

Fischer, Julius C. ;

Bscheider, Michael ;

Eisenkolb, Gabriel ;

Lin, Chia-Ching ;

Wintges, Alexander ;

Otten, Vera ;

Lindemans, Caroline A. ;

Heidegger, Simon ;

Rudelius, Martina ;

Monette, Sebastien ;

Rodriguez, Kori A. Porosnicu ;

Calafiore, Marco ;

Liebermann, Sophie ;

Liu, Chen ;

Lienenklaus, Stefan ;

Weiss, Siegfried ;

Kalinke, Ulrich ;

Ruland, Juergen ;

Peschel, Christian ;

Shono, Yusuke ;

Docampo, Melissa ;

Velardi, Enrico ;

Jenq, Robert R. ;

Hanash, Alan M. ;

Dudakov, Jarrod A. ;

Haas, Tobias ;

van den Brink, Marcel R. M. ;

Poeck, Hendrik .

SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (386)

[39]

Foote J.B., 2017, CANC IMMUNOL RES

[40] STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade [J].

Fu, Juan ;

Kanne, David B. ;

Leong, Meredith ;

Glickman, Laura Hix ;

McWhirter, Sarah M. ;

Lemmens, Edward ;

Mechette, Ken ;

Leong, Justin J. ;

Lauer, Peter ;

Liu, Weiqun ;

Sivick, Kelsey E. ;

Zeng, Qi ;

Soares, Kevin C. ;

Zheng, Lei ;

Portnoy, Daniel A. ;

Woodward, Joshua J. ;

Pardoll, Drew M. ;

Dubensky, Thomas W., Jr. ;

Kim, Young .

SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (283)

← 1 2 3 4 5 6 7 8 9 10 →